Chase C. Leavitt, General Counsel/Secretary at Oncternal Therapeutics, Inc. (ONCT), bought 13,500 shares at $1.78 ($23K) on 2022-01-27, disclosed to the SEC on 2022-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.78 | 8,500 | $15K | 65.0% |
| 2 | $1.63 | 5,000 | $8K | 35.0% |
| Total | $1.72 avg | 13,500 | $23K | 100% |
| Filing → |
| ONCT | BUY | 2023-04-14 | $7K | — | Filing → |
| ONCT | BUY | 2021-06-15 | $8K | — | Filing → |
| LCTX | BUY | 2019-08-15 | $5K | — | Filing → |